Barry Greene

Barry E.
Greene is the founder of VS, Inc., founded in 2014, where the title held is Chief Medical Officer.
Current jobs include Director at Pharmaceutical Research & Manufacturers of America, Lead Independent Director at Karyopharm Therapeutics, Inc. since 2015, Independent Director at BCLS Acquisition Corp.
since 2020, Independent Director at Dyne Therapeutics, Inc. starting 2026, and Advisor at Longwood Fund Management LLC.
Former jobs include President, Chief Executive Officer & Director at SAGE Therapeutics, Inc. from 2020 to 2025; Independent Director at Acorda Therapeutics, Inc. from 2007 to 2021; Director at Intercept Pharmaceuticals, Inc. from 2011 to 2012; Director at Ambrx, Inc. in 2014; Director at Regulus Therapeutics, Inc. from 2007 to 2012; Vice President-Marketing & Customer Services at AstraZeneca PLC from 1998 to 2000; General Manager-Oncology Division at Millennium Pharmaceuticals, Inc. from 2001 to 2003; Chief Business Officer & Executive Vice President at Mediconsult.com, Inc. from 1999 to 2000; Partner at Andersen Consulting LLP (GB) from 1986 to 1998; Partner at Accenture Ltd.; President at Alnylam Pharmaceuticals, Inc. from 2016 to 2020; Vice President-Strategic Integration at AstraZeneca Pharmaceuticals LP.
Education includes undergraduate degree from the University of Pittsburgh.